Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 0 | 0 | 319 | 80 | 11,432 |
| Cost of Goods | 0 | 0 | N/A | N/A | 3,244 |
| Gross Profit | N/A | N/A | 319 | 80 | 8,188 |
| Operating Expenses | 101,497 | 62,190 | 78,722 | 87,427 | 152,245 |
| Operating Income | -101,497 | -62,190 | -78,403 | -87,347 | -143,813 |
| Interest Expense | 56 | 870 | 2,208 | 11,151 | 78,802 |
| Other Income | -134 | 441 | -2,225 | 2,851 | 42,460 |
| Pre-tax Income | -101,687 | -62,619 | -82,836 | -95,647 | -180,155 |
| Net Income Continuous | -101,687 | -62,619 | -82,836 | -95,647 | -180,155 |
| Minority Interests | -313 | -259 | -194 | -252 | -126 |
| Net Income | $-101,374 | $-62,360 | $-82,642 | $-95,395 | $-180,029 |
| EPS Basic Total Ops | -19.80 | -35.30 | -64.70 | -76.50 | -2,099.58 |
| EPS Basic Continuous Ops | -17.49 | -18.26 | -36.30 | -62.60 | -1,865.42 |
| EPS Diluted Total Ops | -19.80 | -35.30 | -64.70 | -76.50 | -2,099.58 |
| EPS Diluted Continuous Ops | -17.49 | -18.26 | -36.30 | -62.60 | -1,865.42 |
| EBITDA(a) | $-99,151 | $-59,779 | $-76,561 | $-85,576 | $-138,585 |